Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by T.E.A. Botrel
PCN10 Targeted Therapy (TT) for First Line Treatment of Advanced Renal Cell Carcinoma (RCC): An Indirect Comparison Meta-Analysis (ICMA)
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Related publications
Targeted Therapy for Renal Cell Carcinoma
Optimal First‐line Treatment for Advanced Thymic Carcinoma
Thoracic Cancer
Medicine
Pulmonary
Respiratory Medicine
Oncology
Cost-Effectiveness Analysis of Sunitinib Versus Interferon-Alfa for First-Line Treatment of Advanced and/or Metastatic Renal Cell Carcinoma in Singapore
International Journal of Technology Assessment in Health Care
Health Policy
Bevacizumab Monotherapy as Salvage Therapy for Advanced Clear Cell Renal Cell Carcinoma Pretreated With Targeted Drugs
Clinical Genitourinary Cancer
Oncology
Urology
Angiogenesis Genotyping in the Selection of First-Line Treatment With Either Sunitinib or Pazopanib for Advanced Renal Cell Carcinoma
Oncotarget
Oncology
Real-World Survival Outcomes and Prognostic Factors Among Patients Receiving First Targeted Therapy for Advanced Renal Cell Carcinoma: A SEER–Medicare Database Analysis
Clinical Genitourinary Cancer
Oncology
Urology
Molecular Subtyping of Metastatic Renal Cell Carcinoma: Implications for Targeted Therapy
Molecular Cancer
Cancer Research
Oncology
Molecular Medicine
Molecular Targeted Agents as Second-Line Treatment for Hepatocellular Carcinoma: A Meta-Analysis and Review
Oncotarget
Oncology
Establishment and Characterization of a Cell Line (Ko-RCC-1) From a Human Renal Cell Carcinoma
Japanese Journal of Urology
Urology
